Rumors surfaced regarding Aurora Cannabis potentially partnering with New Zealand-based MedLeaf Therapeutics for distribution in Germany, with misinformation also circulating on investing.com.
1 report, 0 independent
Updated Jun 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Rumors surfaced regarding Aurora Cannabis potentially partnering with New Zealand-based MedLeaf Therapeutics for distribution in Germany, with misinformation also circulating on investing.com.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Aurora Cannabis Inc., a company based in Canada, operates globally including Europe with GMP-certified facilities in Germany, and its shares trade on the NASDAQ. Miguel Martin is the Executive Chairman and CEO.Also in this story
- Aurora Cannabis, a Canadian medical cannabis company, launched its Whistler Cannabis Co. brand in Australia.
- Aurora Cannabis has successfully navigated regulatory challenges and achieved strong performance in key European markets, including developments related to Poland.
The entities involved
-
investing.com
Online finance portal
-
CanniMed
Canadian public licensed producer of medical cannabis
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet